RecruitingPhase 4

Vending Machine Naloxone Distribution for Your Community (VENDY)

United States4,000 participantsStarted 2024-06-01

Plain-language summary

Vending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxone Distribution for Your community (VENDY) program.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any person in the community who desires to obtain naloxone will be able to use the machines Exclusion Criteria: * Inability to enter a code on a vending machine or open a kiosk.

What they're measuring

Reach

Timeframe: the 6 months pre VENDY implementation and the 6 months post VENDY implementation

Trial details

NCT IDNCT06429436

SponsorUniversity of Colorado, Denver

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-30

Contact for this trial

Nicole Wagner, PhD

(303)724-7095 nicole.wagner@cuanschutz.edu

View on ClinicalTrials.gov More Harm Reduction trials